Antibiotic Dispensing During First Year of COVID-19 Pandemic In Brazilian Public Hospitals

References

• Government of Brasil . Resultados parciais da autoavaliação dos programas de gerenciamento do uso de antimicrobianos (2019). www.gov.br/anvisa/pt-br/assuntos/servicosdesaude/prevencao-e-controle-de-infeccao-e-resistencia-microbiana/gerenciamento-do-uso-de-antimicrobianos-em-servicos-de-saude
   Google Scholar
• Huttner BD , CathoG , Pano-PardoJR , PulciniC , SchoutenJ. COVID-19: don’t neglect antimicrobial stewardship principles!Clin. Microbiol. Infect.26(7), 808–810 (2020).
   PubMed Web of Science ®Google Scholar
• Huang C , WangY , LiXet al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet395(10223), 497–506 (2020).
   PubMed Web of Science ®Google Scholar
• Lucien MAB , CanarieMF , KilgorePEet al. Antibiotics and antimicrobial resistance in the COVID-19 era: perspective from resource-limited settings. Int. J. Infect. Dis.104, 250–254 (2021).
   PubMed Web of Science ®Google Scholar
• Buehrle DJ , DeckerBK , WagenerMMet al. Antibiotic consumption and stewardship at a hospital outside of an early coronavirus disease 2019 epicenter. Antimicrob. Agents Chemother.64(11), e01011–01020 (2020).
   PubMed Web of Science ®Google Scholar
• Cascella M , RajnikM , CuomoA , DulebohnSC , DiNapoli R. Features, evaluation, and treatment of coronavirus (COVID-19). StatPearlsStatPearls Publishing, FL, USA (2023).
   Google Scholar
• Hsu J . How COVID-19 is accelerating the threat of antimicrobial resistance. BMJ369, doi: 10.1136/bmj.m1983 (2020).
   PubMedGoogle Scholar
• Mustafa ZU , SalmanM , AldeyabM , KowCS , HasanSS. Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan. Sn Compr. Clin. Med.3(8), 1691–1695 (2021).
   PubMedGoogle Scholar
• COVID-19 Clinical Management, Living Guidance . WHO,Geneva, Switzerland (2021). www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infectionwhennovel-coronavirus-(ncov)-infection-is-suspected
   Google Scholar
• Government of Brasil . Diretrizes Brasileiras para Tratamento Hospitalar do Paciente com COVID-19–Capítulo 2: Tratamento FarmacológicoBrasília, Brazil (2022).
   Google Scholar
• Nieuwlaat R , MbuagbawL , MertzDet al. COVID-19 and antimicrobial resistance: parallel and interacting health emergencies. Clin. Infect. Dis.72(9), 1657–1659 (2021).
   PubMed Web of Science ®Google Scholar
• Guisado-Gil A , Infante-DomínguezC , PeñalvaGet al. Impact of the COVID-19 pandemic on antimicrobial consumption and hospital-acquired candidemia and multidrug-resistant bloodstream infections. Antibiotics9(11), 816 (2020).
   Google Scholar
• Langford BJ , SoM , RaybardhanSet al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin. Microbiol. Infect.26(12), 1622–1629 (2020).
   PubMed Web of Science ®Google Scholar
• Lansbury L , LimB , BaskaranV , LimWS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J. Infect.81(2), 266–275 (2020).
   PubMed Web of Science ®Google Scholar
• Metlay JP , WatererGW , LongACet al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am. J. Respir. Crit. Care Med.200(7), e45–e67 (2019).
   PubMed Web of Science ®Google Scholar
• BrCAST . Brazilian Committee on Antimicrobial Susceptibility Testing (BrCAST) (2022). https://brcast.org.br/
   Google Scholar
• Jones RN , Guzman-BlancoM , GalesACet al. Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). Braz. J. Infect. Dis.17(6), 672–681 (2013).
   PubMed Web of Science ®Google Scholar
• Phaff SJ , TiddensHAWM , VerbrughHA , OttA. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis. J. Antimicrob. Chemother.57(4), 741–746 (2006).
   PubMed Web of Science ®Google Scholar
• Arteaga-Livias K , Pinzas-AcostaK , Perez-AbadLet al. A multidrug-resistant Klebsiella pneumoniae outbreak in a Peruvian hospital: another threat from the COVID-19 pandemic. Infect. Control Hosp. Epidemiol.43(2), 267–268 (2022).
   PubMed Web of Science ®Google Scholar
• Lai CC , ChenSY , KoWC , HsuehPR. Increased antimicrobial resistance during the COVID-19 pandemic. Int. J. Antimicrob. Agents57(4), doi: 10.1016/j.ijantimicag.2021.106324 (2021).
   Web of Science ®Google Scholar
• Nestler MJ , GodboutE , LeeKet al. Impact of COVID-19 on pneumonia-focused antibiotic use at an academic medical center. Infect. Control Hosp. Epidemiol.42(7), 915–916 (2021).
   PubMed Web of Science ®Google Scholar
• Malik SS , MundraS. Increasing consumption of antibiotics during the COVID-19 pandemic: implications for patient health and emerging anti-microbial resistance. Antibiotics12(1), 45 (2022).
   Google Scholar
• Gouin KA , CreasyS , BeckersonMet al. Trends in prescribing of antibiotics and drugs investigated for COVID-19 treatment in U.S. nursing home residents during the COVID-19 pandemic. Clin. Infect. Dis.74(1), 74–82 (2022).
   PubMed Web of Science ®Google Scholar
• Bogdanić N , MočibobL , VidovićT , SoldoA , BegovaćJ. Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020. PLOS ONE17(2), e0263437 (2022).
   PubMed Web of Science ®Google Scholar
• Gyselinck I , JanssensW , VerhammeP , VosR. Rationale for azithromycin in COVID-19: an overview of existing evidence. BMJ Open Respir. Res.8(1), e000806 (2021).
   PubMed Web of Science ®Google Scholar
• Parnham MJ , ErakovicV , Giamarellos-BourboulisEJ , PerlettiG , VerledenGM , VosR. Pharmacology & therapeutics azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol. Ther.143(2), 225–245 (2014).
   PubMed Web of Science ®Google Scholar
• COVID-19 Rapid Guideline: Managing COVID-19. National Institute for Health and Care Excellence (NICE), London, UK (2023). https://www.ncbi.nlm.nih.gov/books/NBK310330/
   Google Scholar
• Inoue M , KanekoK , AkizawaKet al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–3 (1999–2002). J. Infect. Chemother.12(1), 9–21 (2006).
   PubMedGoogle Scholar
• Jenkins SG , BrownSD , FarrellDJ. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1–4. Ann. Clin. Microbiol. Antimicrob.11, 1–11 (2008).
   Google Scholar
• Machalek DA , TaoY , ShillingHet al. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. Lancet Infect. Dis.20(11), 1302–1314 (2020).
   PubMed Web of Science ®Google Scholar
• Bissessor M , TabriziSN , TwinJet al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin. Infect. Dis.60(8), 1228–1236 (2015).
   PubMed Web of Science ®Google Scholar
• Bradshaw CS , JensenJS , WaitesKB. New horizons in Mycoplasma genitalium treatment. J. Infect. Dis.216(Suppl. 2), S412–S419 (2017).
   PubMedGoogle Scholar
• WHO . Model list of essential medicines (2021). www.who.int/medicines/organization/par/edl/expcom13/eml13_en.pdf
   Google Scholar